News

Back

Genflow Biosciences intention to Float on the London Stock Exchange

January 10th 2022

BSCB Dev

Genflow Biosciences Plc ("Genflow" or "the Company"), a UK-based biotechnology company focused on longevity and the development of therapies to counteract the effects of aging and diseases associated with advanced age, is pleased to announce its intention to seek a listing of its ordinary shares to the Standard Listing segment of the London Stock Exchange.

Read Pdf